OncoFlash – Research updates in a Flash! January 24 edition

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Chang JY, Lin SH, Dong W, Liao Z et  al.; Lancet, 2023 [1]

Source: Clinical Oncology - December 21, 2023 Category: Radiology Authors: D. Shor, R. Simoes Source Type: research